jerome powell digital currency, Featured

US lawmakers say it is too early to lift sanctions against Syria, and US Republican and Democratic senators say it is too early to consider lifting sanctions against Syria after President Assad steps down, which shows that Washington is unlikely to change its policy in the short term.Dennis Shen, an economist at Scope Ratings: The reasons for the Fed to cut interest rates further after December are obviously reduced. Inflation is still sticky, the economic and financial markets are overheated, and the slight increase in unemployment rate earlier this year has been reversed. The Trump administration may bring more inflation risks in the short term.Judiciary Committee of the U.S. House of Representatives: A great deal of evidence has been found that "the financial industry implements conspiracy and antitrust behavior in order to impose extreme ESG targets on American companies".

Turkey said it would crack down on Kurdish armed forces in Syria. Turkish President Erdogan held talks with visiting US Secretary of State Blinken in Ankara on December 12. The two sides discussed the latest situation in Syria and bilateral relations. Erdogan said that Turkey would crack down on all "terrorist organizations" such as the PKK.American polls show that half of Americans lack confidence in Trump's ability to nominate qualified cabinet members. A recent poll by the Associated Press -NORC Public Affairs Research Center shows that half of Americans lack confidence in President-elect Trump's ability to nominate qualified people for the new cabinet or key administrative positions. According to the survey results, 55% of American respondents have "a little confidence" or "no confidence at all" in Trump's ability to select qualified candidates during his second term, and another 27% have "very confidence". The poll was conducted from December 5 to 9, and the respondents were 1251 American adults, with a margin of error of 3.7 percentage points.Barclays raised the target price of Hilton Hotels Group from $243.00 to $268.00.

The latest research results support Harvard's discovery that Novo Nordisk diet drug Ozempic is related to rare visual loss, and the large-scale test results show that Novo Nordisk diet drug Ozempic is related to rare visual loss, which supports the research results given by Harvard University earlier this year. Obese patients who use Ozempic are more than twice as likely to be diagnosed with NAION. NAION occurs when the blood flow decreases and damages the optic nerve. The risk of eye conditions is still low; Patients should pay attention. Novo Nordisk Denmark's share price once fell more than 3.3%.German regulators investigate potential abuse of electricity price increases.WTI crude oil rose 1.5% in the day to 70.71 USD/barrel.